# OnCo record ulixertinib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ulixertinib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ulixertinib" ;
  schema:name "Ulixertinib"@en ;
  schema:alternateName "BVD-523"@en ;
  schema:description "Ulixertinib is an experimental tablet from Biomed Valley Discoveries that blocks ERK, the last switch in a growth signalling chain that drives some cancers. It is being tested in histiocytosis and in gliomas."@en ;
  schema:url <https://onco.cc/drugs/ulixertinib/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://biomed-valley.com/ulixertinib/>, <https://clinicaltrials.gov/study/NCT05804227>, <https://clinicaltrials.gov/study/NCT06411821> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "orphan-designation" ;
  onco:modality "Oral small-molecule kinase inhibitor" ;
  onco:cancers <https://onco.cc/cancers/braf-v600-melanoma/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:targets <https://onco.cc/targets/mapk1/>, <https://onco.cc/targets/mapk3/> ;
  onco:companies <https://onco.cc/companies/biomed-valley-discoveries/> .